Regeneron's Bispecific Therapy Receives Approval for Myeloma; Concentra Set to Acquire IGM

Regeneron’s Bispecific Therapy Receives Approval for Myeloma; Concentra Set to Acquire IGM

Regeneron's Bispecific Therapy Receives Approval for Myeloma; Concentra Set to Acquire IGM